Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 505 to 514 of 514 entries
Sorted by: Best Match Show Resources per page
Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy.

ESMO open

Takada K, Takamori S, Shimokawa M, Toyokawa G, Shimamatsu S, Hirai F, Tagawa T, Okamoto T, Hamatake M, Tsuchiya-Kawano Y, Otsubo K, Inoue K, Yoneshima Y, Tanaka K, Okamoto I, Nakanishi Y, Mori M.
PMID: 34942439
ESMO Open. 2021 Dec 20;7(1):100348. doi: 10.1016/j.esmoop.2021.100348. Epub 2021 Dec 20.

INTRODUCTION: The albumin-bilirubin (ALBI) grade is a novel indicator of the liver function. Some studies showed that the ALBI grade was a prognostic and predictive biomarker for the efficacy of chemotherapy in cancer patients. The association between the ALBI...

Cite
Takada K, Takamori S, Shimokawa M, et al. Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy. ESMO Open. 2021;7(1):100348doi: 10.1016/j.esmoop.2021.100348.
Takada, K., Takamori, S., Shimokawa, M., Toyokawa, G., Shimamatsu, S., Hirai, F., Tagawa, T., Okamoto, T., Hamatake, M., Tsuchiya-Kawano, Y., Otsubo, K., Inoue, K., Yoneshima, Y., Tanaka, K., Okamoto, I., Nakanishi, Y., & Mori, M. (2021). Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy. ESMO open, 7(1), 100348. https://doi.org/10.1016/j.esmoop.2021.100348
Takada, K, et al. "Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy." ESMO open vol. 7,1 (2021): 100348. doi: https://doi.org/10.1016/j.esmoop.2021.100348
Takada K, Takamori S, Shimokawa M, Toyokawa G, Shimamatsu S, Hirai F, Tagawa T, Okamoto T, Hamatake M, Tsuchiya-Kawano Y, Otsubo K, Inoue K, Yoneshima Y, Tanaka K, Okamoto I, Nakanishi Y, Mori M. Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy. ESMO Open. 2021 Dec 20;7(1):100348. doi: 10.1016/j.esmoop.2021.100348. Epub 2021 Dec 20. PMID: 34942439.
Copy Download .nbib Format: NLM
Distinct dual cortico-cortical networks successfully identified between supplemental and primary motor areas during intracranial EEG for drug-resistant frontal lobe epilepsy.

Epilepsy & behavior reports

Inoue T, Uda T, Kuki I, Yamamoto N, Nagase S, Nukui M, Okazaki S, Kawashima T, Nakanishi Y, Kunihiro N, Matsuzaka Y, Kawawaki H, Otsubo H.
PMID: 33554104
Epilepsy Behav Rep. 2021 Jan 19;15:100429. doi: 10.1016/j.ebr.2021.100429. eCollection 2021.

We present a case of drug-resistant focal motor seizures in which separate cortico-cortical epileptic networks within the supplementary motor area (SMA) proper and primary motor area (PMA) were proven by ictal high-frequency oscillation (HFO) and cortico-cortical evoked potential (CCEP)....

Cite
Inoue T, Uda T, Kuki I, et al. Distinct dual cortico-cortical networks successfully identified between supplemental and primary motor areas during intracranial EEG for drug-resistant frontal lobe epilepsy. Epilepsy Behav Rep. 2021;15:100429doi: 10.1016/j.ebr.2021.100429.
Inoue, T., Uda, T., Kuki, I., Yamamoto, N., Nagase, S., Nukui, M., Okazaki, S., Kawashima, T., Nakanishi, Y., Kunihiro, N., Matsuzaka, Y., Kawawaki, H., & Otsubo, H. (2021). Distinct dual cortico-cortical networks successfully identified between supplemental and primary motor areas during intracranial EEG for drug-resistant frontal lobe epilepsy. Epilepsy & behavior reports, 15100429. https://doi.org/10.1016/j.ebr.2021.100429
Inoue, Takeshi, et al. "Distinct dual cortico-cortical networks successfully identified between supplemental and primary motor areas during intracranial EEG for drug-resistant frontal lobe epilepsy." Epilepsy & behavior reports vol. 15 (2021): 100429. doi: https://doi.org/10.1016/j.ebr.2021.100429
Inoue T, Uda T, Kuki I, Yamamoto N, Nagase S, Nukui M, Okazaki S, Kawashima T, Nakanishi Y, Kunihiro N, Matsuzaka Y, Kawawaki H, Otsubo H. Distinct dual cortico-cortical networks successfully identified between supplemental and primary motor areas during intracranial EEG for drug-resistant frontal lobe epilepsy. Epilepsy Behav Rep. 2021 Jan 19;15:100429. doi: 10.1016/j.ebr.2021.100429. eCollection 2021. PMID: 33554104; PMCID: PMC7851778.
Copy Download .nbib Format: NLM
A case of cardiopulmonary arrest due to left ventricular free wall rupture successfully treated with sutureless repair supported by venoarterial extracorporeal membrane oxygenation.

Clinical case reports

Suzuki G, Ichibayashi R, Yamamoto S, Serizawa H, Kawada K, Kameda T, Nakamichi Y, Watanabe M, Okuma S, Honda M.
PMID: 33768812
Clin Case Rep. 2021 Jan 11;9(3):1207-1211. doi: 10.1002/ccr3.3728. eCollection 2021 Mar.

Extracorporeal membrane oxygenation for cardiopulmonary arrest due to left ventricular free wall rupture is considered effective, because it enables rapid cardiopulmonary support and introduction of targeted temperature management.

Cite
Suzuki G, Ichibayashi R, Yamamoto S, et al. A case of cardiopulmonary arrest due to left ventricular free wall rupture successfully treated with sutureless repair supported by venoarterial extracorporeal membrane oxygenation. Clin Case Rep. 2021;9(3):1207-1211doi: 10.1002/ccr3.3728.
Suzuki, G., Ichibayashi, R., Yamamoto, S., Serizawa, H., Kawada, K., Kameda, T., Nakamichi, Y., Watanabe, M., Okuma, S., & Honda, M. (2021). A case of cardiopulmonary arrest due to left ventricular free wall rupture successfully treated with sutureless repair supported by venoarterial extracorporeal membrane oxygenation. Clinical case reports, 9(3), 1207-1211. https://doi.org/10.1002/ccr3.3728
Suzuki, Ginga, et al. "A case of cardiopulmonary arrest due to left ventricular free wall rupture successfully treated with sutureless repair supported by venoarterial extracorporeal membrane oxygenation." Clinical case reports vol. 9,3 (2021): 1207-1211. doi: https://doi.org/10.1002/ccr3.3728
Suzuki G, Ichibayashi R, Yamamoto S, Serizawa H, Kawada K, Kameda T, Nakamichi Y, Watanabe M, Okuma S, Honda M. A case of cardiopulmonary arrest due to left ventricular free wall rupture successfully treated with sutureless repair supported by venoarterial extracorporeal membrane oxygenation. Clin Case Rep. 2021 Jan 11;9(3):1207-1211. doi: 10.1002/ccr3.3728. eCollection 2021 Mar. PMID: 33768812; PMCID: PMC7981659.
Copy Download .nbib Format: NLM
Robot-assisted thoracoscopic esophagectomy for gastrointestinal stromal tumor of the esophagus: A case report.

International journal of surgery case reports

Yamamoto H, Ebihara Y, Tanaka K, Matsui A, Nakanishi Y, Asano T, Noji T, Kurashima Y, Murakami S, Nakamura T, Tsuchikawa T, Okamura K, Shichinohe T, Hirano S.
PMID: 34481133
Int J Surg Case Rep. 2021 Sep;86:106335. doi: 10.1016/j.ijscr.2021.106335. Epub 2021 Aug 26.

INTRODUCTION: A gastrointestinal stromal tumor (GIST) often arises in the stomach and small intestine, while esophageal GIST is rare. The first-choice treatment is surgical resection, but there is no standard technique. Herein, we describe our experience in the treatment...

Cite
Yamamoto H, Ebihara Y, Tanaka K, et al. Robot-assisted thoracoscopic esophagectomy for gastrointestinal stromal tumor of the esophagus: A case report. Int J Surg Case Rep. 2021;86:106335doi: 10.1016/j.ijscr.2021.106335.
Yamamoto, H., Ebihara, Y., Tanaka, K., Matsui, A., Nakanishi, Y., Asano, T., Noji, T., Kurashima, Y., Murakami, S., Nakamura, T., Tsuchikawa, T., Okamura, K., Shichinohe, T., & Hirano, S. (2021). Robot-assisted thoracoscopic esophagectomy for gastrointestinal stromal tumor of the esophagus: A case report. International journal of surgery case reports, 86106335. https://doi.org/10.1016/j.ijscr.2021.106335
Yamamoto, Hiroyuki, et al. "Robot-assisted thoracoscopic esophagectomy for gastrointestinal stromal tumor of the esophagus: A case report." International journal of surgery case reports vol. 86 (2021): 106335. doi: https://doi.org/10.1016/j.ijscr.2021.106335
Yamamoto H, Ebihara Y, Tanaka K, Matsui A, Nakanishi Y, Asano T, Noji T, Kurashima Y, Murakami S, Nakamura T, Tsuchikawa T, Okamura K, Shichinohe T, Hirano S. Robot-assisted thoracoscopic esophagectomy for gastrointestinal stromal tumor of the esophagus: A case report. Int J Surg Case Rep. 2021 Sep;86:106335. doi: 10.1016/j.ijscr.2021.106335. Epub 2021 Aug 26. PMID: 34481133; PMCID: PMC8416945.
Copy Download .nbib Format: NLM
Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma.

Journal of thoracic disease

Nakamura A, Takuwa T, Hashimoto M, Kuroda A, Nakamichi T, Matsumoto S, Kondo N, Kijima T, Hasegawa S.
PMID: 33282372
J Thorac Dis. 2020 Nov;12(11):6712-6721. doi: 10.21037/jtd-20-1910.

BACKGROUND: Evaluation of tumor markers may facilitate follow-up of malignant pleural mesothelioma (MPM). We aimed was to evaluate the value of tumor markers for monitoring and predicting recurrence in patients with MPM.METHODS: In total, 152 patients who underwent curative-intent...

Cite
Nakamura A, Takuwa T, Hashimoto M, et al. Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma. J Thorac Dis. 2020;12(11):6712-6721doi: 10.21037/jtd-20-1910.
Nakamura, A., Takuwa, T., Hashimoto, M., Kuroda, A., Nakamichi, T., Matsumoto, S., Kondo, N., Kijima, T., & Hasegawa, S. (2020). Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma. Journal of thoracic disease, 12(11), 6712-6721. https://doi.org/10.21037/jtd-20-1910
Nakamura, Akifumi, et al. "Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma." Journal of thoracic disease vol. 12,11 (2020): 6712-6721. doi: https://doi.org/10.21037/jtd-20-1910
Nakamura A, Takuwa T, Hashimoto M, Kuroda A, Nakamichi T, Matsumoto S, Kondo N, Kijima T, Hasegawa S. Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma. J Thorac Dis. 2020 Nov;12(11):6712-6721. doi: 10.21037/jtd-20-1910. PMID: 33282372; PMCID: PMC7711396.
Copy Download .nbib Format: NLM
Evaluation of osteoblastic cell behavior upon culture on titanium substrates photo-functionalized by vacuum ultra-violet treatment.

Experimental cell research

Nakashima Y, Akaike M, Kounoura M, Hayashi K, Morita K, Oki Y, Nakanishi Y.
PMID: 34822810
Exp Cell Res. 2022 Jan 01;410(1):112944. doi: 10.1016/j.yexcr.2021.112944. Epub 2021 Nov 22.

Photo-functionalization of titanium orthopedic/prosthetic implants using ultraviolet illumination is known to improve osteogenesis. Therefore, in this study, we aimed to examine the influence of vacuum ultraviolet (VUV)-treated titanium surfaces on osteoblast cell adhesion, activity, and differentiation. Osteoblastic cells were...

Cite
Nakashima Y, Akaike M, Kounoura M, et al. Evaluation of osteoblastic cell behavior upon culture on titanium substrates photo-functionalized by vacuum ultra-violet treatment. Exp Cell Res. 2021;410(1):112944doi: 10.1016/j.yexcr.2021.112944.
Nakashima, Y., Akaike, M., Kounoura, M., Hayashi, K., Morita, K., Oki, Y., & Nakanishi, Y. (2022). Evaluation of osteoblastic cell behavior upon culture on titanium substrates photo-functionalized by vacuum ultra-violet treatment. Experimental cell research, 410(1), 112944. https://doi.org/10.1016/j.yexcr.2021.112944
Nakashima, Yuta, et al. "Evaluation of osteoblastic cell behavior upon culture on titanium substrates photo-functionalized by vacuum ultra-violet treatment." Experimental cell research vol. 410,1 (2022): 112944. doi: https://doi.org/10.1016/j.yexcr.2021.112944
Nakashima Y, Akaike M, Kounoura M, Hayashi K, Morita K, Oki Y, Nakanishi Y. Evaluation of osteoblastic cell behavior upon culture on titanium substrates photo-functionalized by vacuum ultra-violet treatment. Exp Cell Res. 2022 Jan 01;410(1):112944. doi: 10.1016/j.yexcr.2021.112944. Epub 2021 Nov 22. PMID: 34822810.
Copy Download .nbib Format: NLM
The Primates 2021 Social Impact Award.

Primates; journal of primatology

Nakamichi M.
PMID: 34843008
Primates. 2021 Nov 29; doi: 10.1007/s10329-021-00961-3. Epub 2021 Nov 29.

No abstract available.

Cite
Nakamichi M. The Primates 2021 Social Impact Award. Primates. 2021;doi: 10.1007/s10329-021-00961-3.
Nakamichi, M. (2021). The Primates 2021 Social Impact Award. Primates; journal of primatology, . https://doi.org/10.1007/s10329-021-00961-3
Nakamichi, Masayuki. "The Primates 2021 Social Impact Award." Primates; journal of primatology vol. (2021). doi: https://doi.org/10.1007/s10329-021-00961-3
Nakamichi M. The Primates 2021 Social Impact Award. Primates. 2021 Nov 29; doi: 10.1007/s10329-021-00961-3. Epub 2021 Nov 29. PMID: 34843008.
Copy Download .nbib Format: NLM
In Response to Low Skeletal Muscle Mass Is a Risk Factor for Aspiration Pneumonia.

The Laryngoscope

Endo K, Ueno T, Hirai N, Komori T, Nakanishi Y, Kondo S, Wakisaka N, Yoshizaki T.
PMID: 34350990
Laryngoscope. 2021 Aug 05; doi: 10.1002/lary.29792. Epub 2021 Aug 05.

No abstract available.

Cite
Endo K, Ueno T, Hirai N, et al. In Response to Low Skeletal Muscle Mass Is a Risk Factor for Aspiration Pneumonia. Laryngoscope. 2021;doi: 10.1002/lary.29792.
Endo, K., Ueno, T., Hirai, N., Komori, T., Nakanishi, Y., Kondo, S., Wakisaka, N., & Yoshizaki, T. (2021). In Response to Low Skeletal Muscle Mass Is a Risk Factor for Aspiration Pneumonia. The Laryngoscope, . https://doi.org/10.1002/lary.29792
Endo, Kazuhira, et al. "In Response to Low Skeletal Muscle Mass Is a Risk Factor for Aspiration Pneumonia." The Laryngoscope vol. (2021). doi: https://doi.org/10.1002/lary.29792
Endo K, Ueno T, Hirai N, Komori T, Nakanishi Y, Kondo S, Wakisaka N, Yoshizaki T. In Response to Low Skeletal Muscle Mass Is a Risk Factor for Aspiration Pneumonia. Laryngoscope. 2021 Aug 05; doi: 10.1002/lary.29792. Epub 2021 Aug 05. PMID: 34350990.
Copy Download .nbib Format: NLM
Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma.

HPB : the official journal of the International Hepato Pancreato Biliary Association

Yamada T, Nakanishi Y, Hayashi H, Tanishima S, Mori R, Fujii K, Okamura K, Tsuchikawa T, Nakamura T, Noji T, Asano T, Matsui A, Tanaka K, Watanabe Y, Kurashima Y, Ebihara Y, Murakami S, Shichinohe T, Mitsuhashi T, Hirano S.
PMID: 34903468
HPB (Oxford). 2021 Nov 25; doi: 10.1016/j.hpb.2021.11.008. Epub 2021 Nov 25.

BACKGROUND: Lymph node metastasis (LNM) is one of the most adverse prognostic factors in extrahepatic cholangiocarcinoma (EHCC) cases. As next-generation sequencing technology has become more widely available, the genomic profile of biliary tract carcinoma has been clarified. However, whether...

Cite
Yamada T, Nakanishi Y, Hayashi H, et al. Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma. HPB (Oxford). 2021;doi: 10.1016/j.hpb.2021.11.008.
Yamada, T., Nakanishi, Y., Hayashi, H., Tanishima, S., Mori, R., Fujii, K., Okamura, K., Tsuchikawa, T., Nakamura, T., Noji, T., Asano, T., Matsui, A., Tanaka, K., Watanabe, Y., Kurashima, Y., Ebihara, Y., Murakami, S., Shichinohe, T., Mitsuhashi, T., & Hirano, S. (2021). Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma. HPB : the official journal of the International Hepato Pancreato Biliary Association, . https://doi.org/10.1016/j.hpb.2021.11.008
Yamada, Toru, et al. "Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma." HPB : the official journal of the International Hepato Pancreato Biliary Association vol. (2021). doi: https://doi.org/10.1016/j.hpb.2021.11.008
Yamada T, Nakanishi Y, Hayashi H, Tanishima S, Mori R, Fujii K, Okamura K, Tsuchikawa T, Nakamura T, Noji T, Asano T, Matsui A, Tanaka K, Watanabe Y, Kurashima Y, Ebihara Y, Murakami S, Shichinohe T, Mitsuhashi T, Hirano S. Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma. HPB (Oxford). 2021 Nov 25; doi: 10.1016/j.hpb.2021.11.008. Epub 2021 Nov 25. PMID: 34903468.
Copy Download .nbib Format: NLM
The clinical course of 239 cases of Japanese spotted fever in Ise Red Cross Hospital, 2006-2019.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Sakabe S, Tanaka H, Nakanishi Y, Toyoshima H.
PMID: 34711506
J Infect Chemother. 2022 Feb;28(2):211-216. doi: 10.1016/j.jiac.2021.10.014. Epub 2021 Oct 25.

INTRODUCTION: Although the mortality rates associated with Japanese spotted fever (JSF) are unknown, advances in testing technology have led to an increase in JSF-induced mortality reported in clinical practice. Up-to-date clinical information is essential for accurate diagnosis and prompt...

Cite
Sakabe S, Tanaka H, Nakanishi Y, et al. The clinical course of 239 cases of Japanese spotted fever in Ise Red Cross Hospital, 2006-2019. J Infect Chemother. 2021;28(2):211-216doi: 10.1016/j.jiac.2021.10.014.
Sakabe, S., Tanaka, H., Nakanishi, Y., & Toyoshima, H. (2022). The clinical course of 239 cases of Japanese spotted fever in Ise Red Cross Hospital, 2006-2019. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 28(2), 211-216. https://doi.org/10.1016/j.jiac.2021.10.014
Sakabe, Shigetoshi, et al. "The clinical course of 239 cases of Japanese spotted fever in Ise Red Cross Hospital, 2006-2019." Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy vol. 28,2 (2022): 211-216. doi: https://doi.org/10.1016/j.jiac.2021.10.014
Sakabe S, Tanaka H, Nakanishi Y, Toyoshima H. The clinical course of 239 cases of Japanese spotted fever in Ise Red Cross Hospital, 2006-2019. J Infect Chemother. 2022 Feb;28(2):211-216. doi: 10.1016/j.jiac.2021.10.014. Epub 2021 Oct 25. PMID: 34711506.
Copy Download .nbib Format: NLM
Showing 505 to 514 of 514 entries